Last reviewed: July 16, 2026

Last updated: July 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro (tirzepatide) injections have become increasingly popular for weight loss, with clinical trials showing average weight reduction of 21% over 68 weeks at maximum dose. However, the actual cost of this medication can surprise patients—ranging from hundreds to thousands monthly depending on insurance status, dosing frequency, and pharmacy choice. Understanding the true financial picture helps you make an informed decision about your treatment.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

Typical Mounjaro Injection Pricing Without Insurance

The manufacturer's suggested retail price for Mounjaro starts around $1,350 per monthly injection at starting doses and can exceed $1,600 at maintenance levels. For patients paying out-of-pocket without insurance, this represents a significant monthly commitment—potentially $16,000 to $19,000 annually. Many patients discover this cost barrier only after their first pharmacy visit, even with manufacturer discount programs that cap copays at $250.

Additional expenses often appear on the patient's final bill. Pharmacy dispensing fees, clinical consultation charges, and required telehealth visits can add $100 to $300 monthly to the base medication cost. Patients also face variation between retail pharmacies, mail-order services, and specialty pharmacy networks, each with different markup structures and service fees that aren't always transparent upfront.

How Insurance Coverage Affects Your Out-of-Pocket Costs

Insurance plans treat tirzepatide differently depending on whether they classify it as a weight loss medication or diabetes treatment. Plans covering tirzepatide for diabetes may deny coverage for weight loss, leaving patients with full retail costs. Even when coverage is available, many insurers require step-therapy protocols—meaning you must fail other medications first before authorization, delaying your treatment by weeks or months.

Copay structures vary dramatically across insurance types. Some plans charge a flat $50 copay, while others apply 20-40% coinsurance based on the full medication price, making copays $270-$640 per injection. Additionally, many insurance plans cap their annual tirzepatide benefit at specific dollar amounts, meaning patients may hit their coverage limit partway through the year and pay full retail price for remaining doses.

Compounded Tirzepatide as a Transparent Cost Alternative

PlexusDx sources compounded tirzepatide injection from licensed 503A compounding pharmacies, which manufacture medications in smaller batches specifically for individual patients. This approach eliminates manufacturer markup, bulk packaging costs, and corporate profit margins, resulting in significantly lower patient pricing. Compounded tirzepatide through PlexusDx is $289 per month month-to-month, or from $249/mo on the 6-month plan—a flat rate regardless of your dose level—with no insurance requirement and no membership fees.

The transparency benefit matters as much as the price savings. With PlexusDx, patients know exactly what they pay monthly without surprises from insurance denials, step-therapy delays, or benefit exhaustion. Your dose may need to go up. Your price won't. HSA and FSA accounts cover compounded tirzepatide, providing additional tax-advantaged savings for eligible patients. All PlexusDx compounded medications meet 503A pharmacy standards and require a telehealth clinical evaluation before treatment begins.

The Microdose GLP-1 Protocol for Budget-Conscious Patients

Some patients benefit from starting GLP-1 therapy at lower microdoses before advancing to standard maintenance doses. PlexusDx's Microdose GLP-1 Protocol, available at $129 per month flat rate, serves patients exploring whether GLP-1 treatment works for them before committing to higher-dose protocols. This option allows you to assess tolerance, monitor side effects, and determine treatment effectiveness at a significantly lower financial barrier than Mounjaro or standard-dose tirzepatide.

The microdose approach also suits patients managing side effects or those with specific genetic predispositions affecting their medication response. Adding the Precision Peptide Genetic Test ($298) reveals your individual peptide-pathway genetics—including variants in GIPR and FTO, and MC4R genes—helping your provider determine whether microdosing, standard dosing, or dual-compound protocols optimize your results. This personalization prevents unnecessary spending on doses or protocols unlikely to benefit your specific genetic profile.

Comparing Total Annual Costs: Mounjaro vs. PlexusDx Options

A patient using brand-name Mounjaro without insurance faces approximately $16,800 to $19,200 in annual medication costs alone, plus clinic and pharmacy fees bringing total expenses to $18,000-$22,000 yearly. Insured patients with moderate copays ($300-$500 monthly) still spend $3,600-$6,000 annually, and those hitting insurance limits pay thousands more. The financial burden often leads patients to skip doses, delay refills, or abandon treatment entirely—undermining their weight loss progress.

PlexusDx compounded tirzepatide at $289 monthly costs $3,468 annually—a 78-84% savings compared to uninsured Mounjaro patients and 17-43% savings even for insured patients. The Microdose GLP-1 Protocol at $129 monthly totals just $1,548 yearly for those beginning therapy or managing side effects. When you add the Precision Peptide Genetic Test to customize your treatment plan, the total investment remains under $3,000 for your first year—transparent, predictable, and accessible without insurance approval delays.

What's Actually Included in PlexusDx Pricing

Unlike Mounjaro's retail pricing, which covers only the medication itself, PlexusDx flat-rate pricing includes the medication from a licensed 503A compounding pharmacy, telehealth clinical consultation, treatment planning, and ongoing provider access. You're not paying separately for pharmacy markup, clinic overhead, or specialty network markups—just the medication and medical supervision you need. There are no hidden enrollment fees, membership charges, or surprise insurance coordination costs.

PlexusDx operates in all 50 states without insurance gatekeeping, meaning you avoid prior authorization delays, step-therapy failures, or coverage denials that commonly plague Mounjaro patients. Your medication ships directly to your home, and your provider remains available for dose adjustments, side effect management, and outcome tracking throughout your treatment. HSA and FSA eligibility means many patients cover their entire annual cost through pre-tax health savings accounts, effectively reducing their net spending even further.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose GLP-1 Protocol is $129/mo flat. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How much does Mounjaro injection actually cost per month without insurance?

Brand-name Mounjaro costs approximately $1,350-$1,600 per monthly injection at retail price, plus pharmacy fees and clinical consultation charges bringing total monthly costs to $1,500-$1,800 for uninsured patients. PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with no additional hidden fees, representing an 85% cost reduction while maintaining 503A pharmacy quality standards.

Does insurance cover Mounjaro for weight loss, or only for diabetes?

Insurance coverage for Mounjaro depends on your plan's classification. Many plans cover tirzepatide for type 2 diabetes but explicitly exclude weight loss treatment, leaving weight management patients without coverage. Some insurers require step-therapy, meaning you must fail other medications first. PlexusDx eliminates insurance dependency entirely—no prior authorization, no step-therapy, no coverage denials regardless of your health profile.

What's the difference between brand Mounjaro and PlexusDx compounded tirzepatide?

Both contain identical tirzepatide active pharmaceutical ingredient and work through the same biological mechanism. The key difference is sourcing: PlexusDx uses licensed 503A compounding pharmacies that create medication in smaller batches for individual patients, eliminating manufacturer markup and distribution costs. This results in transparent flat pricing ($249/month) versus Mounjaro's retail pricing ($1,500-$1,800/month), with no difference in medication efficacy or safety.

Is the Microdose GLP-1 Protocol right for me if I've never used GLP-1 therapy?

The Microdose GLP-1 Protocol at $129 monthly is ideal for first-time GLP-1 users who want to assess tolerability before committing to standard-dose protocols, or for patients managing side effects. It's also appropriate for individuals with genetic predispositions showing optimal response to lower doses—which the Precision Peptide Genetic Test can reveal. Your provider can recommend the best starting approach based on your medical history and genetic profile.

What does the Precision Peptide Genetic Test tell me about my GLP-1 response?

PlexusDx's Precision Peptide Genetic Test ($298) analyzes 14 peptide-pathway genes including GIPR, FTO, and MC4R variants that influence your weight loss potential and medication response. These genetic insights help your provider determine whether you'll respond best to microdose protocols, standard tirzepatide, semaglutide, or dual-compound options—eliminating guesswork and preventing wasted spending on protocols unlikely to work for your genetics.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

learn